跳至主要内容
临床试验/NL-OMON35011
NL-OMON35011招募中不适用

A prospective, descriptive cohort study evaluating the prevalence and incidence of exocrine pancreatic insufficiency in patients with pancreatic cancer. - Prevalence, incidence of EPI in pancreaticcancer

Academisch Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients who are considered for this trial:
  • - Age >= 18 years.
  • - Malignant tumours of the pancreas, distal cholangiocarcinoma and papillary tumours proven by means of cytology/histology and/or radiology.
  • - are capable and willing to follow instructions given by the physician.

排除标准

  • The following are considered as exclusion criteria:
  • - Subjects who are unwilling or unable to understand and participate in the study and sign the informed consent.
  • - Pre-existent EPI
  • - Pre-existent malabsorption (short bowel disease, IBD, other)
  • - Any known gastro-intestinal disease or major gastrointestinal surgery that could potentially affect the intestinal absorption or metabolism of fat
  • - Total pancreatectomy
  • - Gastroparesis
  • - Pregnancy/lactation
  • - Patients who are suspected not to be reliable in participating in this study, based on the physicians experience.

研究者

相似试验

A prospective, descriptive cohort study evaluating... | 临床试验